Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Puretech Health Plc ADR
(NQ:
PRTC
)
22.00
-1.00 (-4.35%)
Streaming Delayed Price
Updated: 10:34 AM EDT, Aug 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
933
Open
22.08
Bid (Size)
19.86 (1)
Ask (Size)
24.30 (1)
Prev. Close
23.00
Today's Range
22.00 - 22.10
52wk Range
17.08 - 34.00
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
PureTech Founded Entity Seaport Therapeutics Appoints David Wheadon, M.D., to its Board of Directors
August 13, 2024
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Vedanta Biosciences Expands Leadership Team and Appoints Head of Commercial
July 23, 2024
From
PureTech Health plc
Via
Business Wire
Performance
YTD
-12.00%
-12.00%
1 Month
-6.74%
-6.74%
3 Month
-22.83%
-22.83%
6 Month
-0.23%
-0.23%
1 Year
-13.43%
-13.43%
More News
Read More
PureTech Health: Completion of Tender Offer & Total Voting Rights
June 24, 2024
From
PureTech Health plc
Via
Business Wire
PureTech Health: Results of the Tender Offer
June 24, 2024
From
PureTech Health plc
Via
Business Wire
PureTech Announces Change of Board Role
June 20, 2024
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Seaport Therapeutics Appoints Seasoned Executives to Management Team
June 18, 2024
From
PureTech Health plc
Via
Business Wire
PureTech Health: Results of Annual General Meeting
June 13, 2024
From
PureTech Health plc
Via
Business Wire
PureTech Health: Result of General Meeting
June 06, 2024
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Akili Interactive and Virtual Therapeutics Announce Entering Into Definitive Merger Agreement to Establish Leading Digital Health Company
May 29, 2024
From
PureTech Health plc
Via
Business Wire
PureTech to Present at the Jefferies Global Healthcare Conference
May 23, 2024
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Vedanta Biosciences Enrolls First Patient in Pivotal Phase 3 RESTORATiVE303 Study of VE303 for the Prevention of Recurrent C. difficile Infection
May 21, 2024
From
PureTech Health plc
Via
Business Wire
PureTech Health: Launch of Proposed $100 Million Tender Offer at 250 Pence Per Ordinary Share
May 20, 2024
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Seaport Therapeutics Presents Data from Multiple SPT-300 Trials at Society of Biological Psychiatry (SOBP) Annual Meeting
May 09, 2024
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Seaport Therapeutics Adds Industry Veteran to Board of Directors and Makes Key Executive Appointments
May 07, 2024
From
PureTech Health plc
Via
Business Wire
PureTech Announces Annual Results for Year Ended December 31, 2023
April 25, 2024
From
PureTech Health plc
Via
Business Wire
PureTech Health: Notice of Results
April 18, 2024
From
PureTech Health plc
Via
Business Wire
PureTech Announces Completion of Enrollment in Phase 2b ELEVATE IPF Trial of LYT-100 (Deupirfenidone) in Idiopathic Pulmonary Fibrosis
April 16, 2024
From
PureTech Health plc
Via
Business Wire
PureTech Receives FDA Fast Track Designation for LYT-200 in Head and Neck Cancers
April 11, 2024
From
PureTech Health plc
Via
Business Wire
PureTech Launches Seaport Therapeutics with $100 Million Oversubscribed Series A and Announces Management Transitions
April 09, 2024
From
PureTech Health plc
Via
Business Wire
PureTech Proposes $100 Million Capital Return
March 19, 2024
From
PureTech Health plc
Via
Business Wire
Bristol Myers Squibb Completes Acquisition of PureTech's Founded Entity Karuna Therapeutics for $14 Billion
March 18, 2024
From
PureTech Health plc
Via
Business Wire
PureTech Receives Orphan Drug Designation for LYT-200 in Acute Myeloid Leukemia
March 13, 2024
From
PureTech Health plc
Via
Business Wire
PureTech to Present at Two Upcoming Investor Conferences
February 27, 2024
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx ® for Pediatric ADHD Patients in Japan
February 27, 2024
From
PureTech Health plc
Via
Business Wire
PureTech to Present at 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024
From
PureTech Health plc
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.